glp-1 and gip PDB-101: Molecule of the Month: Incretins GIP and GLP-1: similarities and

Pfizer's decision to halt development of the drug came after "a review of the totality of information, including all clinical data generated to date for danuglipron and recent input from regulators," according to a release

Low incidence of anti-drug antibodies in patients with type 2 diabetes treated with once-weekly glucagon-like peptide-1 receptor agonist dulaglutide

2.3.26 ( Covered genome (%), which was the genome regions covered with at least one read per 1 kb-bin, was calculated using BBtools ( The amplification biases of SAGs were evaluated using Gini coefficients and Lorenz curves

Geng, J., Yang, C., Wang, B., Zhang, X., Hu, T., Gu, Y., & Li, J